COVID-19: Govt asks state drug controllers to ensure availability of drugs, med devices

Image
Press Trust of India New Delhi
Last Updated : Apr 22 2020 | 8:08 PM IST

The government on Wednesday asked all state drug controllers to ensure availability of essential medicines and medical devices required in the treatment of COVID-19.

In a meeting with thestate drug controllers,Union Pharma Secretary P D Vaghela asked them "to provide all support to manufacturing units with the help of local administration and concerned authorities by regular interaction so that there is no shortage of medicines and medical devices".

They were also requested to ensure the utilisation of manufacturing capacity to full extent so that sufficient stocks without any hindrance can be made available at all levels, the ministry of chemicals and fertilizers said in a release.

They were instructed to ensure that hoarding and price escalation of drugs and medical devices do not happen and to initiate action in such cases, the release said.

The pharma secretary also asked them to monitor availability of the hydroxychloroquine, azythromycin and paracetamol formulations, the release said.

The state drug controllers were also asked to monitor the list ofessential drugs circulated by the Ministry of Health & Family Welfare on regular basis and to provide the data, it added.

They were asked to provide information of drugs and devices manufacturing units in their states, the release said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 22 2020 | 8:08 PM IST

Next Story